PolyPid Ltd
NASDAQ:PYPD
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
PolyPid Ltd
PolyPid Ltd
Capital Expenditures
PolyPid Ltd
Capital Expenditures Peer Comparison
TEVA
TARO
MDWD
Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors
| Company | Capital Expenditures | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
PolyPid Ltd
NASDAQ:PYPD
|
Capital Expenditures
-$196k
|
CAGR 3-Years
37%
|
CAGR 5-Years
42%
|
CAGR 10-Years
N/A
|
|
|
Teva Pharmaceutical Industries Ltd
TASE:TEVA
|
Capital Expenditures
-$511m
|
CAGR 3-Years
5%
|
CAGR 5-Years
4%
|
CAGR 10-Years
6%
|
|
|
Taro Pharmaceutical Industries Ltd
NYSE:TARO
|
Capital Expenditures
-$54.2m
|
CAGR 3-Years
-47%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-8%
|
|
I
|
InterCure Ltd
TASE:INCR
|
Capital Expenditures
-₪2.6m
|
CAGR 3-Years
50%
|
CAGR 5-Years
-95%
|
CAGR 10-Years
-26%
|
|
|
Mediwound Ltd
NASDAQ:MDWD
|
Capital Expenditures
-$6.2m
|
CAGR 3-Years
-84%
|
CAGR 5-Years
-57%
|
CAGR 10-Years
-32%
|
|
C
|
Cannassure Therapeutics Ltd
TASE:CSURE
|
Capital Expenditures
-₪1.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is PolyPid Ltd's Capital Expenditures?
Capital Expenditures
-196k
USD
Based on the financial report for Dec 31, 2023, PolyPid Ltd's Capital Expenditures amounts to -196k USD.
What is PolyPid Ltd's Capital Expenditures growth rate?
Capital Expenditures CAGR 5Y
42%
Over the last year, the Capital Expenditures growth was 89%. The average annual Capital Expenditures growth rates for PolyPid Ltd have been 37% over the past three years , 42% over the past five years .
You don't have any saved screeners yet
